Long-term efficacy and feasibility of levonorgestrel-releasing intrauterine device use in patients with adenomyosis
Open Access
- 29 May 2020
- journal article
- research article
- Published by Wolters Kluwer Health in Medicine
- Vol. 99 (22) , e20421
Abstract
To evaluate the efficacy and feasibility of levonorgestrel-releasing intrauterine device (LNG-IUD) use longer than 5 years in women with adenomyosis. Data were retrospectively collected from patients who were treated with LNG-IUD longer than 5 years at the Chungnam National University hospital for adenomyosis diagnosed with ultrasonography from January 2006 to November 2013. A total of 131 patients who were diagnosed with adenomyosis had treated with LNG-IUD longer than 5 years. The mean duration of keeping 1 device without replacement was 58.35 ± 15.98 months, and total duration of LNG-IUD treatment was 83.86 ± 23.88 months. A total of 51 patients stopped using LNG-IUD after 5 years and the mean age at the time of LNG-IUD removal was 52.46 ± 6.9. LNG-IUD treatment had a significant effect on both menorrhagia and dysmenorrhea starting from the first month of insertion (P < .01), which persisted until 6 years when the effect started to plateau. The decrease in uterine volume was not consistent during the treatment period. The uterine volume decreased significantly only in the first and second year of LNG-IUD treatment and then from eighth to tenth year of LNG-IUD treatment (P < .05). Adverse events after insertion of LNG-IUD decreased significantly after 5 years. LNG-IUD treatment longer than 5 years is an effective and feasible method for patients diagnosed with adenomyosis.Keywords
This publication has 22 references indexed in Scilit:
- Relationship between uterine volume and discontinuation of treatment with levonorgestrel-releasing intrauterine devices in patients with adenomyosisArchives of Gynecology and Obstetrics, 2016
- Prevalence of chronic low back pain: systematic reviewRevista de Saúde Pública, 2015
- Quality of life and costs of levonorgestrel-releasing intrauterine system or hysterectomy in the treatment of menorrhagia: a 10-year randomized controlled trialAmerican Journal of Obstetrics and Gynecology, 2013
- Levonorgestrel releasing-intrauterine system for the treatment of menorrhagia and/or frequent irregular uterine bleeding associated with uterine leiomyomaThe European Journal of Contraception & Reproductive Health Care, 2011
- Pictorial Blood Loss Assessment Chart in the Evaluation of Heavy Menstrual Bleeding: Diagnostic Accuracy Compared to Alkaline HematinGynecologic and Obstetric Investigation, 2011
- The LNG-IUS study on adenomyosis: a 3-year follow-up study on the efficacy and side effects of the use of levonorgestrel intrauterine system for the treatment of dysmenorrhea associated with adenomyosisContraception, 2009
- Clinical effects of the levonorgestrel-releasing intrauterine device in patients with adenomyosisAmerican Journal of Obstetrics and Gynecology, 2008
- Adenomyosis: what is the impact on fertility?Current Opinion in Obstetrics and Gynecology, 2005
- Assessment of menstrual blood loss using a pictorial chartBJOG: An International Journal of Obstetrics & Gynaecology, 1990
- Adenomyosis: A reappraisal of symptomatologyAmerican Journal of Obstetrics and Gynecology, 1958